RE:RE:RE:Another look at the dataDawg, from what I understand after talking with someone close to the situation is that the FDA have had a number of conversations with TLT managent regarding BTD and the progress of their therapy. I was also told that the FDA has the discretion to "read between the lines" with regards to results, with the possibility that they could disregard much of the botched "first 12" from phase 2. I also believe this is why many of the longs have become more hopeful than ever, and also may be why we have seen such strong insider buying. Nothing is ever certain, but it sure does look good!